{"nct_id":"NCT01441973","title":"Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma","status":"COMPLETED","status_verified_date":"2017-12","start_date":"2011-12-28","start_date_type":"ACTUAL","primary_completion_date":"2014-05-30","primary_completion_date_type":"ACTUAL","completion_date":"2017-01-17","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}